RecruitingNCT04115566

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository


Sponsor

University of California, San Francisco

Enrollment

3,000 participants

Start Date

Aug 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.


Eligibility

Min Age: 10 Years

Inclusion Criteria3

  • Male or female ≥ 10 years of age
  • Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
  • Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

Exclusion Criteria1

  • \. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of California San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04115566


Related Trials